Kimberly-Clark Corporation logo
Kimberly-Clark Corporation KMB
$ 103.1 -0.05%

Quarterly report 2025-Q2
added 08-01-2025

report update icon

Kimberly-Clark Corporation Income Statement 2011-2025 | KMB

Annual Income Statement Kimberly-Clark Corporation

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

45.2 B 40.5 B 43.5 B 43.1 B 41.6 B 49.7 B 37.6 B 41.9 B 43.3 B 46.8 B 40.5 B 39.9 B 32.9 B 27.3 B

Shares

336 M 338 M 337 M 337 M 341 M 343 M 348 M 354 M 359 M 364 M 375 M 384 M 389 M 399 M

Historical Prices

135 120 129 128 122 121 104 95.6 111 106 86.3 80.7 66.7 49.6

Net Income

2.54 B 1.76 B 1.93 B 1.81 B 2.35 B 2.16 B 1.41 B 2.28 B 2.17 B 1.01 B 1.53 B 2.14 B 1.75 B 1.59 B

Revenue

20.1 B 20.4 B 20.2 B 19.4 B 19.1 B 18.4 B 18.5 B 18.3 B 18.2 B 18.6 B 19.7 B 21.2 B 21.1 B 20.8 B

Cost of Revenue

12.9 B 13.4 B 14 B 13.5 B 12.3 B 12.4 B 12.9 B 11.8 B - - - - - -

Gross Profit

7.18 B 7.03 B 6.22 B 5.99 B 6.82 B 6.04 B 5.6 B 6.55 B 6.65 B 6.62 B 6.68 B 7.24 B 6.75 B 6.15 B

Operating Income

3.21 B 2.34 B 2.68 B 2.56 B 3.24 B 2.99 B 2.23 B 3.36 B 3.38 B 1.61 B 2.52 B 2.9 B 2.38 B 2.44 B

Interest Expense

270 M 293 M 282 M 256 M 252 M 261 M 263 M 318 M 319 M 295 M 284 M 282 M 285 M 277 M

EBITDA

3.99 B 3.1 B 3.44 B 3.33 B 4.04 B 3.91 B 3.11 B 4.02 B 4.02 B 2.36 B 3.38 B 4.07 B 3.54 B 3.53 B

Operating Expenses

- - - - - 3.04 B 3.37 B 3.25 B 3.33 B 5.01 B 4.16 B 4.03 B 4.06 B 3.71 B

General and Administrative Expenses

- - - - - 3.25 B 3.37 B 3.23 B 3.33 B 3.44 B 3.71 B 4.03 B 4.07 B -

All numbers in USD currency

Quarterly Income Statement Kimberly-Clark Corporation

2025-Q2 2025-Q1 2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

332 M 332 M 336 M 337 M 337 M 338 M 338 M 338 M - 338 M 337 M 337 M 337 M 337 M 337 M 338 M 339 M 341 M 341 M 341 M 341 M 344 M 344 M 344 M 345 M 347 M 349 M 350 M 351 M 353 M 354 M 356 M 357 M 359 M 360 M 361 M 361 M 364 M 364 M 365 M 365 M 373 M 376 M 379 M 381 M 383 M 385 M 387 M 389 M 394 M 394 M 394 M 396 M 392 M 393 M 403 M

Net Income

509 M 567 M 907 M 544 M 647 M 587 M 102 M 566 M - 467 M 437 M 523 M - 469 M 404 M 584 M - 472 M 681 M 660 M - 671 M 485 M 454 M - 451 M 455 M 93 M - 567 M 531 M 563 M - 550 M 566 M 545 M - 517 M -305 M 468 M - 562 M 509 M 538 M - 546 M 526 M 531 M - 517 M 498 M 468 M 401 M 432 M 408 M 350 M

Revenue

4.16 B 4.84 B 4.95 B 4.23 B 5.15 B 5.13 B 5.13 B 5.2 B - 5.05 B 5.06 B 5.1 B - 5.01 B 4.72 B 4.74 B - 4.68 B 4.61 B 5.01 B - 4.64 B 4.59 B 4.63 B - 4.58 B 4.6 B 4.73 B - 4.66 B 4.58 B 4.5 B - 4.59 B 4.59 B 4.48 B - 4.72 B 4.64 B 4.69 B - 5.06 B 4.95 B 4.89 B - 5.26 B 5.27 B 5.32 B - 5.25 B 5.27 B 5.24 B 5.18 B 5.38 B 5.26 B 5.03 B

Cost of Revenue

2.71 B 3.11 B 3.17 B 2.64 B 3.24 B 3.29 B 3.4 B 3.47 B - 3.51 B 3.53 B 3.58 B - 3.53 B 3.24 B 3.15 B - 3.09 B 2.84 B 3.22 B - 3.08 B 3.11 B 3.2 B - 3.17 B 3.15 B 3.41 B - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

1.46 B 1.73 B 1.78 B 1.59 B 1.91 B 1.84 B 1.73 B 1.73 B - 1.54 B 1.53 B 1.52 B - 1.48 B 1.48 B 1.59 B - 1.59 B 1.78 B 1.79 B - 1.56 B 1.49 B 1.43 B - 1.42 B 1.46 B 1.32 B - 1.67 B 1.65 B 1.66 B - 1.67 B 1.66 B 1.64 B - 1.68 B 1.66 B 1.66 B - 1.76 B 1.7 B 1.66 B - 1.8 B 1.8 B 1.82 B - 1.77 B 1.76 B 1.7 B 1.54 B 1.59 B 1.56 B 1.46 B

Operating Income

592 M 769 M 1.15 B 539 M 853 M 774 M 113 M 787 M - 655 M 621 M 693 M - 657 M 613 M 770 M - 666 M 925 M 904 M - 915 M 670 M 655 M - 669 M 674 M 247 M - 868 M 814 M 848 M - 836 M 838 M 804 M - 779 M -544 M 748 M - 877 M 775 M 711 M - 807 M 796 M 783 M - 783 M 754 M 700 M 611 M 662 M 625 M 544 M

Interest Expense

67 M 64 M 67 M 72 M 67 M 74 M 76 M 73 M - 73 M 68 M 65 M - 64 M 65 M 63 M - 62 M 65 M 61 M - 66 M 67 M 65 M - 64 M 68 M 66 M - 78 M 85 M 83 M - 81 M 81 M 76 M - 74 M 73 M 72 M - 72 M 72 M 71 M - 73 M 71 M 67 M - 70 M 71 M 71 M - 70 M 71 M 64 M

EBITDA

- 987 M - - 1.04 B - - 975 M - 1.22 B 621 M 881 M - 1.23 B 613 M 959 M - 1.27 B 1.34 B 1.12 B - 1.62 B 1.14 B 889 M - 1.32 B 1.11 B 458 M - 1.41 B 1.17 B 1.03 B - 1.36 B 1.19 B 976 M - 1.34 B -161 M 942 M - 1.53 B 1.21 B 929 M - 1.45 B 1.23 B 1 B - 1.42 B 1.19 B 918 M 611 M 1.48 B 1.16 B 787 M

All numbers in USD currency

The income statement is one of the three key financial reports of a company Kimberly-Clark Corporation (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:

  • How much revenue the company earned
  • How much it spent on production, personnel, marketing, taxes, etc.
  • What profit remained in the end

Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.

Features
  • The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
  • Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
  • A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.

Reports on the profits and losses of other stocks in the Household products industry

Issuer Price % 24h Market Cap Country
Natura &Co Holding S.A. Natura &Co Holding S.A.
NTCO
- - $ 9.02 B -
Colgate-Palmolive Company Colgate-Palmolive Company
CL
$ 79.26 1.17 % $ 64.9 B usaUSA
The Clorox Company The Clorox Company
CLX
$ 101.43 -2.46 % $ 12.5 B usaUSA
Dogness (International) Corporation Dogness (International) Corporation
DOGZ
$ 10.06 -4.91 % $ 339 M chinaChina
Coty Coty
COTY
$ 3.24 0.62 % $ 2.82 B usaUSA
Acme United Corporation Acme United Corporation
ACU
$ 40.37 0.95 % $ 149 M usaUSA
The Estée Lauder Companies The Estée Lauder Companies
EL
$ 100.26 -3.68 % $ 36.1 B usaUSA
e.l.f. Beauty e.l.f. Beauty
ELF
$ 78.32 2.58 % $ 4.29 B usaUSA
Church & Dwight Co. Church & Dwight Co.
CHD
$ 85.01 0.47 % $ 20.8 B usaUSA
LifeVantage Corporation LifeVantage Corporation
LFVN
$ 6.48 -0.31 % $ 79.4 M usaUSA
Helen of Troy Limited Helen of Troy Limited
HELE
$ 20.92 -0.38 % $ 481 M bermudaBermuda
Hims & Hers Health Hims & Hers Health
HIMS
$ 36.02 -3.16 % $ 7.78 B usaUSA
Edgewell Personal Care Company Edgewell Personal Care Company
EPC
$ 17.43 0.17 % $ 866 M usaUSA
Nu Skin Enterprises Nu Skin Enterprises
NUS
$ 10.55 -0.61 % $ 524 M usaUSA
Nature's Sunshine Products Nature's Sunshine Products
NATR
$ 23.33 2.59 % $ 445 M usaUSA
Inter Parfums Inter Parfums
IPAR
$ 83.05 -0.42 % $ 2.66 B usaUSA
The Procter & Gamble Company The Procter & Gamble Company
PG
$ 145.14 1.63 % $ 341 B usaUSA
Mannatech, Incorporated Mannatech, Incorporated
MTEX
$ 8.43 -2.54 % $ 15.7 M usaUSA
Revlon Revlon
REV
- -4.41 % $ 212 M usaUSA
United-Guardian United-Guardian
UG
$ 6.03 0.05 % $ 27.7 M usaUSA
Newell Brands Newell Brands
NWL
$ 3.75 -1.71 % $ 1.56 B usaUSA
USANA Health Sciences USANA Health Sciences
USNA
$ 20.3 -0.68 % $ 391 M usaUSA
Unilever PLC Unilever PLC
UL
$ 64.91 -0.05 % $ 132 B britainBritain
Spectrum Brands Holdings Spectrum Brands Holdings
SPB
$ 61.5 0.79 % $ 1.58 B usaUSA